✦ LIBER ✦
CORRIGENDUM: Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
✍ Scribed by Willett, Christopher G; Boucher, Yves; di Tomaso, Emmanuelle; Duda, Dan G; Munn, Lance L; Tong, Ricky T; Chung, Daniel C; Sahani, Dushyant V; Kalva, Sanjeeva P; Kozin, Sergey V
- Book ID
- 109928758
- Publisher
- Nature Publishing Group
- Year
- 2004
- Tongue
- English
- Weight
- 54 KB
- Volume
- 10
- Category
- Article
- ISSN
- 1078-8956
No coin nor oath required. For personal study only.